NCT05208177 2025-08-22A Study of SHR-1802 in Patients With Advanced Solid TumorJiangsu HengRui Medicine Co., Ltd.Phase 2 Terminated25 enrolled
NCT04346381 2023-09-18Study to Evaluate the Efficacy and Safety of Camrelizumab and Famitinib in Patients With Advanced Solid TumorJiangsu HengRui Medicine Co., Ltd.Phase 2 Completed233 enrolled